Markets:

Overview

News

Currencies

International

Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

25.05 +0.28 (+1.13%)

Streaming Delayed Price Updated: 11:59 AM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

30 31 Next >

Boeing, Spirit AeroSystems And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

April 14, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Complete Response Letter Received for AVT02 Biologics License Application

April 13, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Trillions In Biotech Stock Gains Trace Back To This Financier ↗

April 13, 2023

Frank did not grow up as son of a Wall Street banker. He began as the consummate outsider.

Via Investor's Business Daily

Teva to Present New Data on Once-Daily AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets at the 2023 American Academy of Neurology Annual Meeting

April 11, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Emergent BioSolutions Soars: Analyst Upgrades Stock With Near 100% Upside After FDA's Positive Move ↗

April 10, 2023

Via Benzinga

7 A-Rated Stocks to Buy for April 2023 ↗

April 07, 2023

Now that the first quarter's in the bank, here are seven A-rated stocks to buy for April to keep your portfolio in top-notch shape.

Via InvestorPlace

The Byzantine Adderall Shortage Puts Teva And Others In The Hot Seat ↗

April 05, 2023

Millions of people are scrambling to get their ADHD medication. Here's why.

Via Investor's Business Daily

Stage Set For Generics As Biden Admin Asks Supreme Court To Hear Skinny Labels Case Between GSK, Teva ↗

March 31, 2023

Via Benzinga

Is Big Pharma Coming For Your Cannabis Business? ↗

March 27, 2023

Cannabis stocks have struggled in the market in recent years as the industry push to gain ground on the regulatory front hasn't progressed as quickly as investors had hoped. Yet beverage companies...

Via Benzinga

Teva’s Digital Health Collaboration with Rimidi Expands to Include Respiratory Monitoring Program Integration with a Large U.S. Health System

March 27, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

7 Strong Buy Stocks Under $10 to Snap Up Now ↗

March 23, 2023

Markets are missing out on these seven strong buy stocks under $10, which trade at too good a value score for savvy investors to ignore.

Via InvestorPlace

3 No-Brainer Stocks to Buy With $10 Right Now ↗

March 22, 2023

You don't need a large pile of money to begin building wealth on Wall Street.

Via The Motley Fool

Catalyst Pharma The No. 1 Biotech, Just Crushed 2023 Guidance Estimates ↗

March 15, 2023

The guidance includes Catalyst's newest, and second, product.

Via Investor's Business Daily

Teva Announces Early Tender Results of its Debt Tender Offer, Increases to Tender Caps and Election of Early Settlement

March 13, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

7 Core Stocks to Build a Solid Portfolio Around ↗

March 13, 2023

You’ll enjoy your investing journey more if you know that you can rely on your core of stocks to buy to provide a solid foundation.

Via InvestorPlace

Teva and Natco Announce Launch of additional strengths for the Generic Version of Revlimid® (lenalidomide capsules), in the U.S.

March 09, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

BRTX’s ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome

March 09, 2023

By Julian Richard, Benzinga

Via TheNewswire.com

BRTX’s ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome

March 09, 2023

BRTX’s ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome

Via News Direct

BRTX's ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome ↗

March 08, 2023

Metabolism is the chemical process whereby the body produces energy from food. By breaking down carbohydrates and fats into sugars, the cells access fuel that can be used or stored via the liver or...

Via Benzinga

Teva to Present at the Barclays Global Healthcare Conference

March 07, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Better Generics Pharmaceutical Stock: Teva or Viatris? ↗

March 05, 2023

Both have plans to return to growth.

Via The Motley Fool

Teva Announces Successful Upsize and Pricing of $2,490,000,000 (equivalent) Sustainability-Linked Senior Notes and the Increase of the Maximum Tender Amount of its Debt Tender Offer

March 01, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

7 Smart Stock Picks for Cautious Investors ↗

February 28, 2023

As market volatility continues, consider playing it safe with these seven high-quality stocks for cautious investors.

Via InvestorPlace

Teva Announces $2,250,000,000 Debt Tender Offers for Notes Due 2023-2026

February 27, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Announces Launch of $2,060,000,000 (Equivalent) Offering of Sustainability-Linked Senior Notes

February 27, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva to Present New Data from CONNECT2 Study on its Digihaler® System at the American Academy of Allergy, Asthma and Immunology (AAAAI) 2023 Annual Meeting

February 24, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Announces Publication of New Clinician Scale in Journal of Clinical Psychiatry to Assess the Impact of Tardive Dyskinesia on Patients’ Lives

February 23, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Walmart, Home Depot And 3 Stocks To Watch Heading Into Tuesday ↗

February 21, 2023

With US futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, a New Once-Daily Formulation of AUSTEDO® (deutetrabenazine) Tablets

February 17, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

A Patent Cliff Is Coming For Bristol — Can Billions In New Products Fill The Gap? ↗

February 17, 2023

The company's biggest moneymakers are soon to lose patent protection.

Via Investor's Business Daily

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

30 31 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.